E Fund Management »

Regeneron Pharmaceuticals shares owned by E Fund Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by E Fund Management from 13F filings

Historical chart of E Fund Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by E Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by E Fund Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.0k 2 1000.00
2024-06-30 $2.0k 2 1000.00

More positions owned by E Fund Management

PDD Holdings Sponsored Ads (PDD)
iShares Core S&P 500 ETF Core S&p500 Etf (IVV)
Yum China Holdings (YUMC)
KE Holdings Sponsored Ads (BEKE)
SPDR S&P 500 ETF Trust Tr Unit (SPY)
Tencent Music Entertainment G Spon Ads (TME)
H World Group Sponsored Ads (HTHT)
iShares 20 Year Treasury Bon 20 Yr Tr Bd Etf (TLT)
Vipshop Holdings Sponsored Ads A (VIPS)
TAL Education Group Sponsored Ads (TAL)
Kanzhun Sponsored Ads (BZ)
Legend Biotech Corp Sponsored Ads (LEGN)
Qifu Technology American Dep (QFIN)
Vanguard Long-Term Treasury E Long Term Treas (VGLT)
Vanguard Extended Duration Tr Extended Dur (EDV)

View all positions for E Fund Management

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
BlackRock
Jpmorgan Chase & Co
State Street Corporation
Capital World Investors
Capital Research and Management Company - Division 3
Dodge & Cox
Geode Capital Management
Franklin Resources
Morgan Stanley
T. Rowe Price Associates
Invesco
Bank of America Corporation
Amundi

View all funds holding Regeneron Pharmaceuticals